Evidence map›Paper›PMID 37928187›Full record

ArticleFrontiers in cellular and infection microbiology2023

Co-infection and co-localization of Kaposi sarcoma-associated herpesvirus and Epstein-Barr virus in HIV-associated Kaposi sarcoma: a case report.

Peter Julius, Guobin Kang, Stepfanie Siyumbwa, Jane Musumali, For Yue Tso, Owen Ngalamika, Trevor Kaile, Fred Maate, Phyllis Moonga, John T West and 2 more

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Peter JuliusDepartment of Pathology and Microbiology, School of Medicine, University of Zambia, Lusaka, Zambia.
Guobin KangDepartment of Interdisciplinary Oncology, Louisiana State University Health Sciences Center - New Orleans, New Orleans, LA, United States.
Stepfanie SiyumbwaDepartment of Pathology and Microbiology, School of Medicine, University of Zambia, Lusaka, Zambia.
Jane MusumaliUniversity Teaching Hospitals, Eye Hospital, Ministry of Health, Lusaka, Zambia.
For Yue TsoDepartment of Interdisciplinary Oncology, Louisiana State University Health Sciences Center - New Orleans, New Orleans, LA, United States.
Owen NgalamikaDepartment of Pathology and Microbiology, School of Medicine, University of Zambia, Lusaka, Zambia.
Trevor KaileDepartment of Pathology and Microbiology, School of Medicine, University of Zambia, Lusaka, Zambia.
Fred MaateDepartment of Pathology and Microbiology, School of Medicine, University of Zambia, Lusaka, Zambia.
Phyllis MoongaUniversity Teaching Hospitals, Eye Hospital, Ministry of Health, Lusaka, Zambia.
John T WestDepartment of Interdisciplinary Oncology, Louisiana State University Health Sciences Center - New Orleans, New Orleans, LA, United States.
Peter AngelettiNebraska Center for Virology, University of Nebraska-Lincoln, Lincoln, NE, United States.
Charles WoodDepartment of Interdisciplinary Oncology, Louisiana State University Health Sciences Center - New Orleans, New Orleans, LA, United States.
University of Zambia · ZMLouisiana State University Health Sciences Center New Orleans · USMinistry of Health · ZMUniversity of Nebraska–Lincoln · USUniversity Teaching Hospital · ZM

Funding

UNMC/EPPLEY CANCER CENTER SUPPORT GRANTP30CA036727 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI James Eudy · 1985 to 2026
$55.0M
Zambia AIDS Malignancies Diagnosis and Pathogenesis Program SupplementU54CA221204 · NCI · UNIVERSITY OF NEBRASKA LINCOLN · PI WOOD, CHARLES · 2017 to 2022
$3.8M
AIDS Malignancies Training and Research International Program (AMTRIP)D43TW010354 · FIC · UNIVERSITY OF NEBRASKA LINCOLN · PI Chipepo Kankasa, Charles Wood · 2016 to 2026
$2.8M
FIC NIH HHS D43 TW010354NCI NIH HHS P30 CA036727NCI NIH HHS U54 CA221204
6 · The paper itself

Abstract

Kaposi sarcoma (KS), a multifocal vascular neoplasm frequently observed in HIV-positive individuals, primarily affects the skin, mucous membranes, visceral organs, and lymph nodes. KS is associated primarily with Kaposi sarcoma-associated herpesvirus (KSHV) infection. In this case report, we present a rare occurrence of co-infection and co-localization of KSHV and Epstein-Barr virus (EBV) in KS arising from the conjunctiva, which, to our knowledge, has not been reported previously. Immunohistochemistry (IHC), DNA polymerase chain reaction (PCR), and EBV-encoded RNA

Indexed as

Acquired Immunodeficiency SyndromeCoinfectionEpstein-Barr Virus InfectionsHerpesviridae InfectionsHerpesvirus 8, HumanSarcoma, KaposiHerpesvirus 4, HumanHumansco-infectionco-localizationEpstein-Barr virusHIVKaposi sarcomaKaposi sarcoma-associated herpesvirusZambia

Identifiers

PMID37928187
PMCPMC10623342
OpenAlexW4387810276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.